International Tax Review

TP Week

Skip to main content Skip to Navigation menu Skip to Login form

TP Week is now available on your mobile

Site links

Follow us on:
Advanced search | Change font size:   

Navigation Menu

Skip to main content Skip to top of page

Home Page

Subscriptions

Other Services

Poll

How do you rate your relationship with your CFO

Very good, they understand TP requirements well enough
8%
Good but there's room for improvement
30%
Good but TP is not their main concern
52%
They do not understand the requirements of the TP department
10%


View previous poll results

Skip to Navigation menu Skip to top of page

Print Print   Print Email this article to a colleague

Pakistan accuses pharmaceutical companies of malpractice

June 30, 2010

The Federal Board of Revenue (FBR) in Pakistan believes pharmaceutical companies have used transfer pricing to evade Rp500 million ($5.8 million) in taxes.

Reports have emerged of audits being conducted of 12 leading pharmaceutical companies by the large taxpayers unit (LTU) in Karachi . Some of the companies involved are Smith Kline and French of Pakistan Limited, Pfizer Laboratories Limited, Sanofi Aventis Pakistan Limited and Reckitt Benckiser Pakistan Limited.

Free Trial

Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.


Email:
Password:

Remember me?
Forgot your password?

The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our terms and conditions and privacy policy before using the site. All material subject to strictly enforced copyright laws. © 2007 Euromoney Institutional Investor PLC. For help please see our FAQ.